Reduced Graphene Oxides Modulate the Expression of Cell Receptors and Voltage-Dependent Ion Channel Genes of Glioblastoma Multiforme
Overview
Chemistry
Molecular Biology
Authors
Affiliations
The development of nanotechnology based on graphene and its derivatives has aroused great scientific interest because of their unusual properties. Graphene (GN) and its derivatives, such as reduced graphene oxide (rGO), exhibit antitumor effects on glioblastoma multiforme (GBM) cells in vitro. The antitumor activity of rGO with different contents of oxygen-containing functional groups and GN was compared. Using FTIR (fourier transform infrared) analysis, the content of individual functional groups (GN/exfoliation (ExF), rGO/thermal (Term), rGO/ammonium thiosulphate (ATS), and rGO/ thiourea dioxide (TUD)) was determined. Cell membrane damage, as well as changes in the cell membrane potential, was analyzed. Additionally, the gene expression of voltage-dependent ion channels (, , , , , , , and ) and extracellular receptors was determined. A reduction in the potential of the U87 glioma cell membrane was observed after treatment with rGO/ATS and rGO/TUD flakes. Moreover, it was also demonstrated that major changes in the expression of voltage-dependent ion channel genes were observed in , , and after treatment with rGO/ATS and rGO/TUD flakes. Furthermore, the GN/ExF, rGO/ATS, and rGO/TUD flakes significantly reduced the expression of extracellular receptors (uPar, CD105) in U87 glioblastoma cells. In conclusion, the cytotoxic mechanism of rGO flakes may depend on the presence and types of oxygen-containing functional groups, which are more abundant in rGO compared to GN.
Radiosensitizing properties of dual-functionalized carbon nanostructures loaded with temozolomide.
Milenkovska R, Geskovski N, Shalabalija D, Mihailova L, Makreski P, Lukarski D Beilstein J Nanotechnol. 2025; 16:229-251.
PMID: 39995757 PMC: 11849551. DOI: 10.3762/bjnano.16.18.
Hao T, Li Y, Ren Q, Zeng Y, Gao L, Zhu W Mol Ther Oncol. 2025; 33(1):200919.
PMID: 39866243 PMC: 11760297. DOI: 10.1016/j.omton.2024.200919.
Kodous A, Taha E, El-Maghraby D, Hassana A, Atta M Sci Rep. 2024; 14(1):11535.
PMID: 38773159 PMC: 11109164. DOI: 10.1038/s41598-024-60347-5.
Theranostic Applications of 2D Graphene-Based Materials for Solid Tumors Treatment.
Iannazzo D, Celesti C, Giofre S, Ettari R, Bitto A Nanomaterials (Basel). 2023; 13(16).
PMID: 37630966 PMC: 10459055. DOI: 10.3390/nano13162380.
Potential Role of Carbon Nanomaterials in the Treatment of Malignant Brain Gliomas.
Caffo M, Curcio A, Rajiv K, Caruso G, Venza M, Germano A Cancers (Basel). 2023; 15(9).
PMID: 37174040 PMC: 10177363. DOI: 10.3390/cancers15092575.